Deletion mapping of chromosome region 12q13-24 in colorectal cancer

Cancer Genetics and Cytogenetics

Volumn 201, Issue 1, 2010, Pages 32-38

  Aytekin, Turkan ^a   Ozaslan, Mehmet ^a   Cengiz, Beyhan ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 12Q; CHROMOSOME DELETION; CHROMOSOME MAP; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; SEQUENCE DELETION;

EID: 77954654427     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.05.005     Document Type: Article

References (42)

1. Souglakos J. Genetic alterations in sporadic and hereditary colorectal cancer: implementations for screening and follow-up. Dig Dis 2007, 25:9-19.
2. Cetin E., Cengiz B., Gunduz E., Gunduz M., Nagatsuka H., Beder-Beder L., et al. Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers. Neoplasma 2008, 55:299-304.
3. Velasco A., Pallares J., Santacana M., Yeramian A., Dolcet X., Eritja N., et al. Loss of heterozygosity in endometrial carcinoma. Int J Gynecol Pathol 2008, 27:305-317.
4. Ross D.W. Introduction to oncogenes and molecular cancer medicine 1998, Springer, New York.
5. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971, 68:820-823.
6. Peng Z., Zhang F., Zhou C., Ling Y., Bai S., Liu W., et al. Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer. Int J Gastrointest Cancer 2003, 34:39-47.
7. Choi S.W., Lee K.J., Bae Y.A., Min K.O., Kwon M.S., Kim K.M., et al. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res 2002, 8:2311-2322.
8. Popat S., Stone J., Houlston R.S. Allelic imbalance in colorectal cancer at the CRAC1 locus in early-onset colorectal cancer. Cancer Genet Cytogenet 2003, 145:70-73.
9. Zhou C.Z., Qiu G.Q., Zhang F., He L., Peng Z.H. Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma. World J Gastroenterol 2004, 10:1431-1435.
10. Kapitanović S., Cacev T., Radosević S., Spaventi S., Spaventi R., Pavelić K. APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia. Exp Mol Pathol 2004, 77:193-200.
11. Cacev T., Radosević S., Spaventi R., Pavelić K., Kapitanović S. NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut 2005, 54:1129-1135.
12. Chang S.C., Lin J.K., Lin T.C., Liang W.Y. Loss of heterozygosity: an independent prognostic factor of colorectal cancer. World J Gastroenterol 2005, 11:778-784.
13. Zheng H.T., Peng Z.H., Zhou C.Z., Li D.P., Wang Z.W., Qiu G.Q., et al. Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer. World J Gastroenterol 2005, 11:1668-1672.
14. Wan J., Li H., Li Y., Zhu M.L., Zhao P. Loss of heterozygosity of Kras2 gene on 12p12-13 in Chinese colon carcinoma patients. World J Gastroenterol 2006, 12:1033-1037.
15. Mao X., Hamoudi R.A., Talbot I.C., Baudis M. Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II. Cancer Genet Cytogenet 2006, 167:1-14.
16. Sano T., Tsujino T., Yoshida K., Nakayama H., Haruma K., Ito H., et al. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 1991, 51:2926-2931.
17. Rutherford S., Hampton G.M., Frierson H.F., Moskaluk A. Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma. Lab Invest 2005, 85:1076-1085.
18. Orita H., Sakamoto N., Ajioka Y., Terai T., Hino O., Sato N., et al. Allelic loss analysis of early-stage flat-type colorectal tumors. Ann Oncol 2006, 17:43-49.
19. Kimura M., Abe T., Sunamura M., Matsuno S., Horii A. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: identification of a 1-cM region of common allelic loss. Genes Chromosomes Cancer 1996, 17:88-93.
20. Kimura M., Furukawa T., Abe T., Yatsuoka T., Youssef E.M., Yokoyama T., et al. Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer. Cancer Res 1998, 58:2456-2460.
21. Yatsuoka T., Sunamura M., Furukawa T., Fukushige S., Yokoyama T., Inoue H., et al. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma. Am J Gastroenterol 2000, 95:2080-2085.
22. Vogelstein B., Gillespie D. Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci USA 1979, 76:615-619.
23. Bandea Cl, Kubota K., Brown T.M., Kilmarx P.H., Bhullar V., Yanpaisarn S., et al. Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp 1). Sex Transm Infect 2001, 77:419-422.
24. Lee T.L., Leung W.K., Lau J.Y.W., Tong J.H.M., Ng E.K.W., Chan F.K.L., et al. Inverse association between cyclooxygenase-2 overexpression and microsatellite instability in gastric cancer. Cancer Lett 2001, 168:133-140.
25. Reischl U., Bretagne S., Krüger D., Ernault P., Costa J.M. Comparison of two DNA targets for the diagnosis of toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis 2003, 3:7.
26. Mayall F., Barratt K., Shanks J. The detection of simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols. J Clin Pathol 2003, 56:728-730.
27. Kámory E., Csókay B., Holló Z. Rapid detection of cystic fibrosis transmembrane conductance regulator gene IVS8 5T variant by real-time PCR. Clin Chem 2004, 50:1837-1839.
28. Slowik A., Borratynska A., Pera J., Betlej M., Dziedzic T., Krzyszkowski T., et al. II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm. Stroke 2004, 35:1594-1597.
29. Gunduz M., Ouchida M., Fukushima K., Hanafusa H., Etani T., Nishioka S., et al. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res 2000, 60:3143-3146.
30. Zheng H.T., Jiang L.X., Lv Z.C., Li D.P., Zhou C.Z., Gao J.J., et al. Are there tumor suppressor genes on chromosome 4p in sporadic colorectal carcinoma?. World J Gastroenterol 2008, 14:90-94.
31. Balmain A. New-age tumour suppressors. Nature 2002, 417:235-237.
32. Fey M.F., Hesketh C., Wainscoat J.S., Gendler S., Thein S.L. Clonal allele loss in gastrointestinal cancers. Br J Cancer 1989, 59:750-754.
33. Wang H.L., Bai H., Li Y., Sun J., Wang X.Q. Rationales for expression and altered expression of apoptotic protease activating factor-1 gene in gastric cancer. World J Gastroenterol 2007, 13:5060-5064.
34. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Res 1989, 49:4682-4689. [Erratum in: Cancer Res 1990;50:1352].
35. Ohta M., Seto M., Ijichi H., Miyabayashi K., Kudo Y., Mohri D., et al. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Gastroenterology 2009, 136:206-216.
36. Kolfschoten I.G.M., Leeuwen B., Berns K., Mullenders J., Beijersbergen R.L., Bernards R., et al. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005, 121:849-858.
37. 2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proc Natl Acad Sci USA 2007, 104:12353-12358.
38. El-Rifai W., Rutherford S., Knuutila S., Frierson H.F., Moskaluk C.A. Novel DNA copy number losses in chromosome 12q12-13 in adenoid cystic carcinoma. Neoplasia 2001, 3:173-178.
39. Ren B., Yu Y.P., Tseng G.C., Wu C., Chen K., Rao U.N., et al. Analysis of integrin α7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma. J Natl Cancer Inst 2007, 99:868-880.
40. Park Y.M., Kwon J.A., Kelly L.A., George R.D., Mackey J.A., Adachi H., et al. HGNT-IV-H and FEEL-2/stabilin 2 represent potential candidate pancreatic cancer tumor suppressor genes localized to 12q21-23. Proc Annu Meet Am Assoc Cancer Res 2005, 46. [Abstract].
41. Ren C., Li L., Yang G., Timme T.L., Goltsov A., Ren C., et al. RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer. Cancer Res 2004, 64:969-976.
42. Ganapathy V., Gopal E., Miyauchi S., Prasad P.D. Biological functions of SLC5A8, a candidate tumor suppressor. Biochem Soc Trans 2005, 33:237-240.